Medios AGMEDOF 88 Forward PE Ratio is 37.76 as of Jul. 06, 2026. GuruFocus rates MEDOF with a GF Score™ of 88/100 and a GF Value™ of $70.33. The stock has 2 warning signs investors should review. Among 51 Medical Distribution companies, Medios AG ranks better than 68.63% on this metric.
Medios AG (OTCPK:MEDOF) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Medios AG Forward PE Ratio Related Terms
Medios AG Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Medios AG's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medios AG Forward PE Ratio Chart
Medios AG Annual Data
Trend
2024-12
2025-12
Forward PE Ratio
35.06
31.49
Medios AG Quarterly Data
2024-12
2025-03
2025-06
2025-09
2025-12
2026-03
Forward PE Ratio
35.06
39.62
23.97
23.21
31.49
31.15
MEDOF vs MCK, CAH, COR: Forward PE Ratio Comparison
For the Medical Distribution subindustry, Medios AG's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medios AG Forward PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Medios AG's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Medios AG's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Medios AG (MEDOF) has a Forward PE Ratio of 37.76 as of Jul. 06, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Medios AG and its competitors. According to the industry distribution chart, Medios AG ranks #16 out of 51 companies in the Medical Distribution industry, placing it in the top 31.4%.
Is Medios AG's Forward PE Ratio too high?
Medios AG's current Forward PE Ratio is 37.76. The Medical Distribution industry median Forward PE Ratio is 13.92. Medios AG's value of 37.76 is 171.3% above this industry median. Based on the distribution chart, Medios AG ranks #16 out of 51 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Medios AG has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Medios AG's Forward PE Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medios AG ranks #16 out of 51 companies for Forward PE Ratio. This puts Medios AG in the upper half of its industry. The industry median Forward PE Ratio is 13.92. Medios AG's value of 37.76 is 171.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Distribution company?
The median Forward PE Ratio among Medical Distribution companies is 13.92, based on 51 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medios AG's current Forward PE Ratio of 37.76 is 171.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Medios AG and its competitors. For the Medical Distribution industry, the median Forward PE Ratio is 13.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medios AG's current Forward PE Ratio is 37.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medios AG stock overvalued right now?
Medios AG (MEDOF) has a current Forward PE Ratio of 37.76. The stock's GF Value™ is $70.33, compared to a current price of $50.00 — trading 28.9% below its estimated fair value. The current Forward PE Ratio is 37.76 and 171.3% above the Medical Distribution industry median of 13.92. Medios AG's overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Medios AG (MEDOF), the current Forward PE Ratio is 37.76 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medios AG (MEDOF) Overvalued in 2026?
Based on GuruFocus' analysis, Medios AG stock appears to be undervalued.
The current stock price of $50.00 is trading 28.9% below its estimated GF Value™ of $70.33.
Key valuation signals for MEDOF:
Forward PE Ratio: 37.76
GF Value™: $70.33 vs. price of $50.00 (28.9% below fair value)
Industry Position: 171.3% above the Medical Distribution median (#16 of 51)
No single metric tells the full story. See the MEDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medios AG is engaged as a wholesaler for pharmaceutical medicinal products. The operating segments of the company includes: Patient-Specific Therapies: This area includes the compounding of medications on behalf of pharmacies in Germany. Pharmaceautical Supply: Medios is speciality pharma supplier company in germany, producing it own production facilities, hospitals, and Pharmacies. International Business: It includes all business and activities happening in international business.
88GF Score
Get the complete analysis for MEDOF
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEDOF has been successfully added to your 